JP2008542367A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008542367A5 JP2008542367A5 JP2008514588A JP2008514588A JP2008542367A5 JP 2008542367 A5 JP2008542367 A5 JP 2008542367A5 JP 2008514588 A JP2008514588 A JP 2008514588A JP 2008514588 A JP2008514588 A JP 2008514588A JP 2008542367 A5 JP2008542367 A5 JP 2008542367A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cyanomethyl
- phenyl
- carboxamide
- quinoline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 CC1C=CC(C(*)N(C(c2c(CC#N)c(C3=CC=C*(*)C=C3)nc3c2cccc3)=O)I)=CC=C1 Chemical compound CC1C=CC(C(*)N(C(c2c(CC#N)c(C3=CC=C*(*)C=C3)nc3c2cccc3)=O)I)=CC=C1 0.000 description 1
- AQFLVLHRZFLDDV-VIFPVBQESA-N CC[C@@H](c1ccccc1)N Chemical compound CC[C@@H](c1ccccc1)N AQFLVLHRZFLDDV-VIFPVBQESA-N 0.000 description 1
- ZLQPXWZKRCEEHM-HSZRJFAPSA-N CC[C@H](c1ccccc1)NC(c1c(CC#N)c(-c2cccc(F)c2)nc2c1cccc2)=O Chemical compound CC[C@H](c1ccccc1)NC(c1c(CC#N)c(-c2cccc(F)c2)nc2c1cccc2)=O ZLQPXWZKRCEEHM-HSZRJFAPSA-N 0.000 description 1
- OBXIJGKFCRSVFY-UHFFFAOYSA-N N#CCc1c(C(NC(C2CC2)c2cc(F)ccc2)=O)c(cccc2)c2nc1-c1ccccc1 Chemical compound N#CCc1c(C(NC(C2CC2)c2cc(F)ccc2)=O)c(cccc2)c2nc1-c1ccccc1 OBXIJGKFCRSVFY-UHFFFAOYSA-N 0.000 description 1
- WJCDZNCXXWHQFR-UHFFFAOYSA-N N#CCc1c(C(O)=O)c(cccc2)c2nc1-c1cccc(F)c1 Chemical compound N#CCc1c(C(O)=O)c(cccc2)c2nc1-c1cccc(F)c1 WJCDZNCXXWHQFR-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68741805P | 2005-06-03 | 2005-06-03 | |
| PCT/SE2006/000630 WO2006130080A2 (en) | 2005-06-03 | 2006-05-30 | Quinoline derivatives as nk3 anatgonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008542367A JP2008542367A (ja) | 2008-11-27 |
| JP2008542367A5 true JP2008542367A5 (cg-RX-API-DMAC7.html) | 2009-07-16 |
Family
ID=37482086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008514588A Pending JP2008542367A (ja) | 2005-06-03 | 2006-05-30 | Nk−3アンタゴニストとしてのキノリン誘導体 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20080200500A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1891012A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2008542367A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20080016591A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101189211A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006253054A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2611060A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL187410A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2007014831A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20080033L (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006130080A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008131779A1 (en) | 2007-04-26 | 2008-11-06 | H. Lundbeck A/S | Isoquinolinone derivatives as nk3 antagonists |
| US8173639B2 (en) | 2007-04-26 | 2012-05-08 | H. Lundbeck A/S | Isoquinolinone derivatives as NK3 antagonists |
| AR072198A1 (es) | 2008-06-23 | 2010-08-11 | Lundbeck & Co As H | Derivados de isoquinolinona como antagonistas de nk3 y composiciones farmaceuticas que los contienen |
| US8242134B2 (en) | 2008-09-15 | 2012-08-14 | H. Lundbeck A/S | Isoquinolinone derivatives as NK3 antagonists |
| AR073891A1 (es) | 2008-10-20 | 2010-12-09 | Lundbeck & Co As H | Derivados de isoquinolinona antagonistas de receptores nk3, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de psicosis, alzheimer y otras enfermedades. |
| TW201143768A (en) | 2009-12-15 | 2011-12-16 | Lundbeck & Co As H | Pyridone derivatives as NK3 antagonists |
| TW201144311A (en) | 2010-03-12 | 2011-12-16 | Lundbeck & Co As H | Azaisoquionolinone derivatives as NK3 antagonists |
| US10314835B2 (en) | 2014-06-25 | 2019-06-11 | Emory University | Methods of managing conditioned fear with neurokinin receptor antagonists |
| KR20160069683A (ko) | 2014-12-09 | 2016-06-17 | 백찬욱 | 콤비보트 및 그 제작 방법 |
| US11458129B2 (en) | 2017-11-02 | 2022-10-04 | California Institute Of Technology | Neurokinin antagonists and uses thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69531458T2 (de) * | 1994-05-27 | 2004-08-05 | Glaxosmithkline S.P.A. | Chinolinderivate als tachykinin nk3 rezeptor antagonisten |
| IT1270615B (it) * | 1994-07-14 | 1997-05-07 | Smithkline Beecham Farma | Uso di derivati di chinolina |
| AR004735A1 (es) * | 1995-11-24 | 1999-03-10 | Smithkline Beecham Spa | Quinoleina 4-amido sustituida, un procedimiento para su preparacion, una composicion farmaceutica que los contiene y el uso de los mismos para lapreparacion de un medicamento. |
| GB9524137D0 (en) * | 1995-11-24 | 1996-01-24 | Smithkline Beecham Spa | Novel compounds |
| CN1264378A (zh) * | 1997-05-23 | 2000-08-23 | 史密丝克莱恩比彻姆股份公司 | 作为nk-2和nk-3受体拮抗剂的喹啉-4-甲酰胺衍生物 |
| AP1201A (en) * | 1997-09-17 | 2003-09-01 | Smithkline Beecham Corp | Method for the synthesis of quinoline derivatives. |
| JP2002530377A (ja) * | 1998-11-20 | 2002-09-17 | スミスクライン・ビーチャム・ソシエタ・ペル・アチオニ | Nk−3およびnk−2受容体アンタゴニストとしてのキノリン−4−カルボキシアミド誘導体 |
| EP1385839B1 (en) * | 2001-04-11 | 2006-02-22 | GlaxoSmithKline S.p.A. | 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| US20080280949A1 (en) * | 2005-08-11 | 2008-11-13 | Astrazeneca Ab | Oxopyridyl Quinoline Amides as Nk3 Receptor Modulators |
| AR058051A1 (es) * | 2005-09-21 | 2008-01-23 | Astrazeneca Ab | Quinolinas de alquilnitrilo.proceso de obtencion y composiciones farmaceuticas. |
| US20090054445A1 (en) * | 2006-01-27 | 2009-02-26 | Astrazeneca Ab | Amide Substituted Quinolines |
-
2006
- 2006-05-30 CA CA002611060A patent/CA2611060A1/en not_active Abandoned
- 2006-05-30 WO PCT/SE2006/000630 patent/WO2006130080A2/en not_active Ceased
- 2006-05-30 KR KR1020077027965A patent/KR20080016591A/ko not_active Withdrawn
- 2006-05-30 MX MX2007014831A patent/MX2007014831A/es not_active Application Discontinuation
- 2006-05-30 EP EP06747824A patent/EP1891012A2/en not_active Withdrawn
- 2006-05-30 CN CNA2006800196735A patent/CN101189211A/zh active Pending
- 2006-05-30 JP JP2008514588A patent/JP2008542367A/ja active Pending
- 2006-05-30 US US11/914,583 patent/US20080200500A1/en not_active Abandoned
- 2006-05-30 AU AU2006253054A patent/AU2006253054A1/en not_active Abandoned
-
2007
- 2007-11-15 IL IL187410A patent/IL187410A0/en unknown
-
2008
- 2008-01-03 NO NO20080033A patent/NO20080033L/no unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8071621B2 (en) | Alkylsulphonamide quinolines | |
| JP2008542367A (ja) | Nk−3アンタゴニストとしてのキノリン誘導体 | |
| JP2004525184A (ja) | Nk−3およびnk−2受容体アンタゴニストとしての3−置換キノリン−4−カルボキサミド誘導体 | |
| CN101268053A (zh) | 作为nk-3受体配体的烷基腈喹啉 | |
| US20080200504A1 (en) | Amide Alkyl Pyridiyl Quinolines as Nk3 Receptor Modulators | |
| CN101208304A (zh) | 作为nk3受体调节剂的喹啉3-磺酸酯 | |
| CN101282964A (zh) | 作为nk3受体调节剂的氧-吡啶基喹啉酰胺 | |
| CN101370782A (zh) | 烷基磺酰胺喹啉 | |
| CN101268052A (zh) | 作为nk-3受体配体的n-氧代-杂环和n-氧代-烷基喹啉-4-甲酰胺 | |
| US20080287492A1 (en) | Alkylpyridyl Quinolines as Nk3 Receptor Modulators | |
| KR20090122253A (ko) | 퀴놀린 유도체, 이를 포함하는 제약 조성물, 및 중추신경계 및 말초 질환의 치료에서의 이의 용도 | |
| JP2009508946A (ja) | Nk−3受容体リガンドとしてのアルキルスルホキシドキノリン類 |